logo

Endocyte, Inc. (ECYT)



Trade ECYT now with
  Date
  Headline
5/9/2018 2:28:03 PM Wedbush Is Increasing Endocyte, Inc. (ECYT) FY18 Estimate To -0.69 From -0.98
5/9/2018 2:27:45 PM Wedbush Is Increasing Endocyte, Inc. (ECYT) Q2 18 Estimate To -0.15 From -0.24
5/9/2018 8:10:19 AM Endocyte Announces The Lancet Oncology Publication Of Phase 2 Data From Prostate Cancer Trial Of (177)Lu-PSMA-617
5/9/2018 8:10:04 AM Endocyte Q1 Net Loss $8.6 Mln Or $0.16/Shr Vs Net Loss $11.5 Mln Or $0.27/Shr Last Year
2/28/2018 9:19:58 AM Endocyte Prices Public Offering Of 17.86 Mln Shares At $4.20 Per Share
2/27/2018 4:02:37 PM Endocyte Appoints Patrick Machado To Its Board Of Directors
2/26/2018 2:09:32 PM Wedbush Is Cutting Endocyte, Inc. (ECYT) 2018 Estimate To -0.98 From -0.79
2/26/2018 2:09:15 PM Wedbush Is Cutting Endocyte, Inc. (ECYT) 4Q18 Estimate To -0.28 From -0.23
2/26/2018 2:08:53 PM Wedbush Is Lowering Endocyte, Inc. (ECYT) 3Q18 Estimate To -0.26 From -0.21
2/26/2018 2:08:38 PM Wedbush Is Cutting Endocyte, Inc. (ECYT) 2Q18 Estimate To -0.24 From -0.19
2/26/2018 2:08:10 PM Wedbush Is Cutting Endocyte, Inc. (ECYT) 1Q18 Estimate To -0.20 From -0.17
2/26/2018 8:18:18 AM Endocyte Announces Phase 3 VISION Trial And Updates On Corporate Strategy
11/7/2017 11:25:35 AM Wedbush Is Increasing Endocyte, Inc. (ECYT) 2018 Estimate To -0.79 From -0.89